PGHL
NSEProcter & Gamble Health Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹6,839.00
227.00 (3.43%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹11.35K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
33.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹4,707+45.3%
52W High₹6,941-1.5%
Current Price
₹6,839.00
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹5,471.20
Upper Circuit₹8,206.80
Reference Price
₹6,839.00
Investment Checklist
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹7124.1
Ascending Channel on 1D — target ₹7044.17
Composite score 76.46 (STRONG_BUY) with 89.8% confidence
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
3-day momentum: +9.4% — strong upward pressure
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
90%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
6321.94
EMA50
5987.35
EMA200
5706.76
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹6700.00
₹6603.80
₹6369.60
₹6280.40
₹6180.00
Volume Analysis
TrendINCREASING
Change+103.80%
Unusual Volume
Yes (4.43x avg)
Stop Loss Levels
Fixed Risk
1% Risk₹6770.61
3% Risk₹6633.83
5% Risk₹6497.05
7% Risk (Custom)
₹6360.27Technical Levels
1x ATR (Volatility)₹6650.18
2x ATR (Swing)₹6461.36
3x ATR (Trend)₹6272.54
Immediate Support₹6700.00
Moving Averages
EMA 9 (Short-term)₹6458.16
EMA 20 (Medium-term)₹6321.94
EMA 50 (Trend)₹5987.35
EMA 200 (Long-term)₹5706.76
Financials
Financial Analysis
| Metric | Sep '24 | Dec '24 | Mar '25 | Jun '25 |
|---|---|---|---|---|
| Revenue | ₹313.4 Cr | ₹309.8 Cr | ₹311 Cr | ₹338.7 Cr |
| Net Profit | ₹82.3 Cr | ₹90.9 Cr | ₹61.2 Cr | ₹66.2 Cr |
| EPS | ₹49.60 | ₹54.76 | ₹36.86 | ₹39.87 |
| Operating Profit | ₹117.3 Cr | ₹127.4 Cr | ₹84 Cr | ₹94.4 Cr |
ROE
37.34%
ROCE
50.03%
Debt/Equity
0.02
Current Ratio
2.39
OPM
27.86%
NPM
19.54%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Procter & Gamble Health Limited | ₹6,839.00 | +3.43% | 33.6 | ₹11.35K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 12 Feb 2026 | Interim Dividend - Rs 110 Per Share & Special Dividend Rs 50 Per Share | SPECIAL_DIVIDEND |
| 22 Aug 2025 | Dividend - Rs 45 Per Share | DIVIDEND |
| 21 Feb 2025 | Interim Dividend - Rs 80 Per Share | INTERIM_DIVIDEND |
| 28 Nov 2024 | Annual General Meeting/Dividend - Rs 60 Per Share | AGM |
| 14 Feb 2024 | Interim Dividend - Rs 50 Per Share & Special Dividend Rs 150 Per Share | SPECIAL_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
| Date | Purpose | Type |
|---|---|---|
| 06 Aug 2026 | Financial Results | RESULTS |
Latest News
News for PGHL
View AllNEWS
positive
Business Standard - Markets 23d ago
Volumes jump at Procter & Gamble Hygiene and Health Care Ltd counter
Procter & Gamble Hygiene and Health Care Ltd saw volume of 6.2 lakh shares by 10:47 IST on BSE, a 320.13 fold spurt over two-week average daily volume of 1937 shares
AGARWALEYEAMRUTANJANBSEMEDANTAMHHLPGHHPGHLZOTAFast Moving Consumer GoodsFinancial Services
neutral
ET Markets - Industry 24d ago
P&G India flags pressure on consumer demand, input costs
Procter and Gamble India sees rising costs and softening urban demand, with company executives saying inflation will impact consumer spending. However, despite near-term challenges, P&G maintains a positive long-term outlook for India.
CONSUMERLTGILTBEESPGHHPGHLURBANURBANCOConsumer ServicesFast Moving Consumer Goods
NEWS
positive
Business Standard - Markets 43d ago
Procter & Gamble Hygiene and Health Care standalone net profit declines 1.90% in the March 2026 quarter
Sales decline 5.20% to Rs 937.67 crore
AGARWALEYEAMRUTANJANMEDANTAMHHLPGHHPGHLZOTAFast Moving Consumer GoodsHealthcare